On the Fly News and insights, exclusive to thefly.com

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

1. STOCK NEWS:

• Levi Strauss (LEVI) reported mixed Q3 results and said it has initiated a review of strategic alternatives for its Dockers brand
• The FDA determined that Eli Lilly's (LLY) weight loss drug shortage is over
• Constellation Brands (STZ) reported upbeat Q2 results and provided FY25 guidance
• The state of Texas is suing insulin manufacturers and pharmacy benefit managers over insulin prices
• EVgo (EVGO) jumped following receipt of a conditional commitment for a $1.05B DOE loan guarantee as well as upgrades by JPMorgan and TD Cowen 

2. WALL STREET CALLS:

• Wolfspeed (WOLF) downgraded to Underperform at Mizuho on slower expected global EV sales
• Evercore ISI downgraded Tractor Supply (TSCO) to In Line
• Evercore also downgraded Academy Sports (ASO) to In Line ASO
• Stellantis (STLA) downgraded at Barclays, here's why
• BofA upgraded InvenTrust Properties (IVT) to Buy from Neutral

3. AROUND THE WEB:

• Helix Energy (HLX) is working with advisers to weigh a possible sale, Bloomberg reports
• Blue Owl (OWL) is in talks to buy IPI Partners for $1B, Bloomberg says
• Toyota (TM) plans to push back the production of electric vehicles in North America to the first half of 2026, Nikkei says
• TotalEnergies (TTE) CEO said the company will curb its investments in the UK and restructure its operations in the North Sea if the government increases a windfall tax, FT reports
• Google (GOOGL) is considering how to bring electricity from nuclear power plants to its data centers, Nikkei reports

4. MOVERS:

• Pennant Group (PNTG) higher after announcing a 3.5M share offering
• Supermicro (SMCI) gains after entering a strategic collaboration with Fujitsu Limited (FJTSY)
• Hims & Hers (HIMS) falls after the FDA said the shortage of Eli Lilly's (LLY) weight loss drug is over
• Equinox (EQX) lower in New York after announcing a convertible note conversion
• Sabre (SABR) declines after signing a long-term distribution agreement with Arajet

5. EARNINGS/GUIDANCE:

• Albany International (AIN) provided guidance for FY24
• AngioDynamics (ANGO) reported Q1 results, with EPS beating consensus
• Nano Dimension (NNDM) reported preliminary Q3 revenue
• BigCommerce (BIGC) reaffirmed its Q3 guidance as part of its CEO change announcement
• Fenbo Holdings (FEBO) reported 1H results, with EPS lower year-over-year

INDEXES:

The Dow fell 184.93, or 0.44%, to 42,011.59, the Nasdaq lost 6.65, or 0.037%, to 17,918.48, and the S&P 500 declined 9.60, or 0.17%, to 5,699.94.